These results prompted us to aim for the appropriately designed substituents at alcoholic hydroxyl groups at C-3 and C-23 for 5,7,20-O-trimethylsilybin (3) in hopes to enhance the antiproliferative potency and selectivity towards AR-positive prostate cancer cells. Here, AR is linked to prostate carcinoma.